Showing 3361-3370 of 6060 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0709_04-php/22799/How Viable is Pay-for-Performance in Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0509_03-php/22825/Though Pay-for-Performance has affected primary care medicine for years, it has only recently expanded into specialized medicine. Experts discuss its eventual impact on dermatology.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0509_05-php/22827/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0309_06-php/22860/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0209_05-php/22877/Lead Psoriasis Patients Along the Path to Clearance
https://practicaldermatology.com/topics/psoriasis/PD0209_01-php/22873/With so many effective therapies now available, dermatologists must be prepared to guide their patients to the right treatment for their specific presentation.- George W. Mahaffey Named CEO of Mindera Corporationhttps://practicaldermatology.com/news/george-w-mahaffey-named-ceo-of-mindera-corporation/2460480/George W. Mahaffey is the new President and Chief Executive Officer of Mindera Corporation. He will also serve as a Director of the Company. Mindera has developed a novel platform to extract thousands of biomarkers from an individual patient via a dermal biomarker patch. Captured R
- Cynosure Appoints Timothy W. Baker as Presidenthttps://practicaldermatology.com/news/20140730-cynosure_appoints_timothy_w_baker_as_president/2459154/The Board of Directors of Cynosure, Inc., which develops and markets laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, promoted Executive Vice President, Chief Operating Officer and Chief Financial Officer Timothy W. Baker to Presi